| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |